Commentary
Pfizer now claims the right of a corporate sovereign, arguing that states have “no legitimate interest in regulating” the company’s commercial speech while demanding the power to censor Americans’ newsfeeds.
Pfizer now claims the right of a corporate sovereign, arguing that states have “no legitimate interest in regulating” the company’s commercial speech while demanding the power to censor Americans’ newsfeeds.